Else Nutrition
  • Else Nutrition (BABY) announced that Walmart is adding Baby Super Cereal to the range of Else products available in store
  • Walmart will start selling Else Super Cereal in Original and Vanilla flavors in approximately 500 stores across the country
  • Else Nutrition is a food and nutrition company
  • Else Nutrition Holdings Inc. (BABY) is up 2.41 per cent, trading at C$0.85 per share at 10:03 am ET

Else Nutrition (BABY) announced that Walmart is adding Baby Super Cereal to the range of Else products available in store.

The company updated that the Baby Super Cereal is the first and only US baby cereal clean label certified brand. Walmart will start selling Else Super Cereal in Original and Vanilla flavors in approximately 500 stores across the country.

Hamutal Yitzhak, CEO of Else Nutrition, commented on the news.

“We are extremely proud of our relationship with Walmart and the commitment we share to our joint success in the plant-based early nutrition category. We recognize that working closely with the nation’s largest retailer is a key step in bringing our minimally processed, whole-plant clean and safe of heavy metals feeding approach to millions of families across America.”

The company reported that since Super Cereal reached best-seller status on Amazon.com in Q3 2022, it has seen increased demand for the product amongst consumers and retailers. Adding the cereal range to shelves at Walmart will expose further consumers to the category-leading product. It will also increase availability for those already seeking it.

About Else Nutrition Holdings 

Else Nutrition is a food and nutrition company. It focuses on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults.

The company’s revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at Milan’s Global Food Innovation Summit.

Else Nutrition Holdings Inc. (BABY) is up 2.41 per cent, trading at C$0.85 per share at 10:03 am ET.

More From The Market Online

@ the Bell: TSX recovers and S&P hits fresh high

Energy shares led enough of a rally to overcome industrials and tech losses to push the TSX to a positive end on Tuesday.

Pathologists group accepts Telo Genomics’ test for rare blood cancer

The College of American Pathologists accepts the Telo Genomics' (TSXV:TELO) submission of a test for a rare blood cancer.

Theralase adds cancer immunotherapy to potential revenue streams

Theralase Technologies' (TSXV:TLT) lead drug candidate, Rutherrin, enhanced cancer immunotherapy in a pre-clinical setting.